The three US benchmark indices rallied for the second trading day as fears of omicron are fading off after the White House's medical advisor Fauci indicates the new Covid variant is less severe than being of concern according to the early data.
The Dow Jones Industrial Average rose 1.4%, S&P 500 advanced 2.07%, and Nasdaq jumped 3.03%. The tech sector jumped 3% and led the broader market gains as investors bought the dip in the growth stocks. The Mega-cap tech giants all had decent gains on Tuesday. Apple rose 2.86% after Morgan Stanley raised its price target to $200. Amazon, Microsoft, and Alphabet were all up more than 2%, while Meta Platform gained more than 1%.
The EV maker, Tesla Motor, also recovered losses. Rivian, known as the electric-vehicle trucking startup, slipped 1.35% after its share jumped near 10% the previous day. While Lucid fell 2.89%.
The chipmakers had a winning day. Intel's share surged 7% before it cut gains and closed 2.55% higher. Nvidia rose 6.92%, and AMD was up 4%.
Energy stocks continued to rebound as crude oil prices rebounded for the last two trading days amid optimism towards economic recovery after the positive comments on omicron from US officials. Devon Energy was up 6.49%, and Occidental gained 4.28%.
The WTI futures added 1.95%, to $71.42.
Gold futures were up $7.5, to $1,787.1 per ounce.
The US 10-year Treasury yield rose to 1.478%.
Disclaimer: CMC Markets Singapore may provide or make available research analysis or reports prepared or issued by entities within the CMC Markets group of companies, located and regulated under the laws in a foreign jurisdictions, in accordance with regulation 32C of the Financial Advisers Regulations. Where such information is issued or promulgated to a person who is not an accredited investor, expert investor or institutional investor, CMC Markets Singapore accepts legal responsibility for the contents of the analysis or report, to the extent required by law. Recipients of such information who are resident in Singapore may contact CMC Markets Singapore on 1800 559 6000 for any matters arising from or in connection with the information.
